Saravolatz, Louis D <br/><br/>
In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).  [electronic resource] 

 -  International journal of antimicrobial agents  Nov 2010 
 - 478-80 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7913 
<br/><br/><label>Standard No.: </label>10.1016/j.ijantimicag.2010.07.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Bacterial Typing Techniques<br/>Cephalosporins--pharmacology<br/>DNA Fingerprinting<br/>DNA, Bacterial--genetics<br/>Daptomycin--pharmacology<br/>Drug Resistance, Bacterial<br/>Electrophoresis, Gel, Pulsed-Field<br/>Humans<br/>Microbial Sensitivity Tests<br/>Staphylococcal Infections--microbiology<br/>Staphylococcus aureus--classification